Stockholders' Equity (Tables)

6 Months Ended

12 Months Ended

Jun. 30, 2023

Dec. 31, 2022

Stockholder's Equity [Abstract]

Schedule of Company’s Warrant Activity

The following is a summary of the Company’s warrant activity for the six months ended June 30, 2023 (unaudited):

			Weighted		Weighted
			Average		Average
	Number of		Exercise		Remaining
	Shares		Price		Life
Outstanding at December 31, 2022		153,683	$	36.96	2.96 Years
Granted		344,212	$	3.39	4.87 Years
Exercised/cancelled		-
		497,895	$	13.75	4.13 Years

Schedule of Grant Date Fair Value of Options Granted

The Company determined the grant date fair value of options granted for the six months ended June 30, 2023, using the Black Scholes Method with the following assumptions:

Expected volatility	120.32%-124.08%
Expected term	5 years
Risk free rate	3.52% - 3.97%
Dividend rate	0.00%

The Company determined the grant date fair value of the options granted during the years ended December 31, 2022 and 2021 using the Black Scholes and Monte-Carlo Method as appropriate and the following assumptions:

	2022		2021
Expected volatility		123-127%		70%
Expected term		5 Years		1.0-5.0 Years
Risk free rate		2.14-3.75%		0.16-1.27&
Dividend rate		0.00%		0.00%

Schedule of Related to Stock Options

Activity related to stock options for the six months ended June 30, 2023 (unaudited), is summarized as follows:

				Weighted		Weighted
				Average		Average	Aggregate
	Number of			Exercise		Contractual	Intrinsic
	Shares			Price		Term (Yrs.)	Value
Outstanding at December 31, 2022		1,291,595		$	46.48	6.5	$	-
Granted		630,625		$	4.19	10.0	$	1,847,765
Exercised		-		$	-	-	$	-
Forfeited/cancelled		(361,150	)	$	52.86	-	$	-
Outstanding as of June 30, 2023		1,561,070		$	28.19	6.7	$	1,881,165
Exercisable as of June 30, 2023		810,268		$	40.28	4.4	$	40,899

Activity related to stock options for the years ended December 31, 2022, and 2021 is summarized as follows:

				Weighted		Weighted
				Average		Average		Aggregate
	Number of			Exercise		Contractual		Intrinsic
	Shares			Price		Life (Yrs.)		Value
Outstanding, January 1, 2021		705,726		$	36.00		7.5	$	8,283,639
Granted		572,952		$	60.48		10.0	$	-
Exercised		(74,958	)	$	10.32		5.0	$	3,485,482
Forfeited/cancelled		(89,845	)	$	52.16		8.8	$	-
Outstanding, December 31, 2021		1,113,875		$	51.84		6.7	$	67,488,214
Granted		248,168		$	12.88		10.0	$	-
Exercised		(49,712	)	$	18.56		8.8	$	-
Forfeited/cancelled		(20,765	)	$	52.96		7.9	$	-
Outstanding, December 31, 2022		1,291,566		$	46.48		6.5	$	-
Exercisable, December 31, 2022		697,158		$	46.88		4.5	$	-

Schedule of Stock Option

The following table summarizes stock option information as of June 30, 2023 (unaudited):

			Weighted
			Average
			Contractual
Exercise Price	Outstanding		Term (Yrs.)	Exercisable
Less than or equal $32.00		1,155,716	7.4		515,052
$32.01 - $56.00		17,917	3.0		17,917
$56.01 - $80.00		222,792	6.3		131,820
$80.01 - $128.00		164,645	3.4		145,479
		1,561,070	6.7		810,268

The following table summarizes stock option information as of December 31, 2022:

			Contractual
Exercise Price	Outstanding		Life (Yrs.)		Exercisable
$0.24 - $32.00		637,936		5.9		399,223
$32.01 - $56.00		18,958		3.6		18,958
$56.01 - $80.00		427,017		8.3		113,996
$80.01 - $127.76		207,655		4.9		164,981
		1,291,566		6.5		697,158

Schedule of Warrant Activity

The following is a summary of the Company’s warrant activity for the years ended December 31, 2022 and 2021:

				Weighted		Weighted
				Average		Average
	Number of			Exercise		Remaining
	Shares			Price		Life
Outstanding, January 1, 2021		227,909		$	33.60		3.4 Years
Granted		8,036		$	70.00		5.0 Years
Exercised/Cancelled		(60,493	)	$	25.76		-
Outstanding, December 31, 2021		175,452		$	36.88		3.0 Years
Granted		17,837		$	29.60		5.0 Years
Exercised/Cancelled		(39,635	)	$	33.20		0.1 Years
Outstanding, December 31, 2022		153,654		$	36.96		2.96 Years